effect of hormone replacement therapy on sex hormones and tumor markers in cervical squamous cell carcinoma postoperative patients

Clicks: 255
ID: 245783
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #38 of 96 articles by views in journal of communications

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Objective: To investigate the effect of hormone replacement therapy on sex hormones and tumor markers in cervical squamous cell carcinoma postoperative patients. Methods: A total of 100 cases of cervical squamous cell carcinoma from January 2012 to December 2014 in our hospital were selected as research objects, and the observation group (58 cases) were willing to receive hormone replacement therapy, while the control group (42 cases) were not willing to receive hormone replacement therapy, with routine treatment. Before and after treatment, the serum levels of neutral hormone and tumor markers were detected in two groups of patients. Results: Before treatment, there were no significant differences in serum E2, FSH and LH levels between the two groups (all P>0.05); after treatment, in the observation group compared with before treatment, the level of serum E2 increased significantly (P<0.05), and was significantly higher than the control group after treatment (P<0.05), compared with before treatment, serum FSH and LH levels decreased significantly (P<0.05), and were significantly lower than those of the control group after treatment(P<0.05); in the control group after treatment, the serum E2 level was slightly decreased, FSH and LH levels were slightly elevated, but there was no statistical difference (all P>0.05). Before and after treatment, the levels of serum SCC-Ag, VEGF-C, M MP-2 and MMP-9 showed no significant differences between the two groups (all P>0.05). Conclusions: The use of hormone replacement therapy in cervical squamous cell carcinoma patients can significantly improve the adverse symptoms caused by low estrogen, improve the quality of life of patients, and not affect the prognosis of patients in the short term.
Reference Key
ding2016journaleffect Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Hong-Yan Ding;Hong-Ge Xu;Jin-Yu Gao;Yu-Chen Song
Journal journal of communications
Year 2016
DOI
DOI not found
URL
http://www.hnykdxxb.com/PDF/201623/19.pdf
Keywords
sex hormone hormone replacement therapy

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.